Cargando…

A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China

BACKGROUND: Patients with type 2 diabetes Mellitus (T2DM) are more likely to suffer from a higher uric acid level in blood—hyperuricemia (HUA). There are no conclusive studies done to predict HUA among T2DM patients. Therefore, this study aims to explore the risk factors of HUA among T2DM patients a...

Descripción completa

Detalles Bibliográficos
Autores principales: Abudureyimu, Palizhati, Pang, Yuesheng, Huang, Lirun, Luo, Qianqian, Zhang, Xiaozheng, Xu, Yifan, Jiang, Liang, Mohemaiti, Patamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483783/
https://www.ncbi.nlm.nih.gov/pubmed/37679683
http://dx.doi.org/10.1186/s12889-023-16669-6
_version_ 1785102457394692096
author Abudureyimu, Palizhati
Pang, Yuesheng
Huang, Lirun
Luo, Qianqian
Zhang, Xiaozheng
Xu, Yifan
Jiang, Liang
Mohemaiti, Patamu
author_facet Abudureyimu, Palizhati
Pang, Yuesheng
Huang, Lirun
Luo, Qianqian
Zhang, Xiaozheng
Xu, Yifan
Jiang, Liang
Mohemaiti, Patamu
author_sort Abudureyimu, Palizhati
collection PubMed
description BACKGROUND: Patients with type 2 diabetes Mellitus (T2DM) are more likely to suffer from a higher uric acid level in blood—hyperuricemia (HUA). There are no conclusive studies done to predict HUA among T2DM patients. Therefore, this study aims to explore the risk factors of HUA among T2DM patients and finally suggest a model to help with its prediction. METHOD: In this retrospective research, all the date were collected between March 2017 and October 2019 in the Medical Laboratory Center of the First Affiliated Hospital of Xinjiang Medical University. The information included sociodemographic factors, blood routine index, thyroid function indicators and serum biochemical markers. The least absolute shrinkage and selection operator (LASSO) and multivariate binary logistic regression were performed to screen the risk factors of HUA among T2DM patients in blood tests, and the nomogram was used to perform and visualise the predictive model. The receiver operator characteristic (ROC) curve, internal validation, and clinical decision curve analysis (DCA) were applied to evaluate the prediction performance of the model. RESULTS: We total collected the clinical date of 841 T2DM patients, whose age vary from 19-86. In this study, the overall prevalence of HUA in T2DM patients was 12.6%. According to the result of LASSO-logistic regression analysis, sex, ethnicity, serum albumin (ALB), serum cystatin C (CysC), serum inorganic phosphorus (IPHOS), alkaline phosphatase (ALP), serum bicarbonate (CO2) and high-density lipoprotein (HDLC) were included in the HUA risk prediction model. The nomogram confirmed that the prediction model fits well (χ(2) = 5.4952, P = 0.704) and the calibration curve indicates the model had a good calibration. ROC analysis indicates that the predictive model shows the best discrimination ability (AUC = 0.827; 95% CI: 0.78–0.874) whose specificity is 0.885, and sensitivity is 0.602. CONCLUSION: Our study reveals that there were 8 variables that can be considered as independent risk factors for HUA among T2DM patients. In light of our findings, a predictive model was developed and clinical advice was given on its use.
format Online
Article
Text
id pubmed-10483783
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104837832023-09-08 A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China Abudureyimu, Palizhati Pang, Yuesheng Huang, Lirun Luo, Qianqian Zhang, Xiaozheng Xu, Yifan Jiang, Liang Mohemaiti, Patamu BMC Public Health Research BACKGROUND: Patients with type 2 diabetes Mellitus (T2DM) are more likely to suffer from a higher uric acid level in blood—hyperuricemia (HUA). There are no conclusive studies done to predict HUA among T2DM patients. Therefore, this study aims to explore the risk factors of HUA among T2DM patients and finally suggest a model to help with its prediction. METHOD: In this retrospective research, all the date were collected between March 2017 and October 2019 in the Medical Laboratory Center of the First Affiliated Hospital of Xinjiang Medical University. The information included sociodemographic factors, blood routine index, thyroid function indicators and serum biochemical markers. The least absolute shrinkage and selection operator (LASSO) and multivariate binary logistic regression were performed to screen the risk factors of HUA among T2DM patients in blood tests, and the nomogram was used to perform and visualise the predictive model. The receiver operator characteristic (ROC) curve, internal validation, and clinical decision curve analysis (DCA) were applied to evaluate the prediction performance of the model. RESULTS: We total collected the clinical date of 841 T2DM patients, whose age vary from 19-86. In this study, the overall prevalence of HUA in T2DM patients was 12.6%. According to the result of LASSO-logistic regression analysis, sex, ethnicity, serum albumin (ALB), serum cystatin C (CysC), serum inorganic phosphorus (IPHOS), alkaline phosphatase (ALP), serum bicarbonate (CO2) and high-density lipoprotein (HDLC) were included in the HUA risk prediction model. The nomogram confirmed that the prediction model fits well (χ(2) = 5.4952, P = 0.704) and the calibration curve indicates the model had a good calibration. ROC analysis indicates that the predictive model shows the best discrimination ability (AUC = 0.827; 95% CI: 0.78–0.874) whose specificity is 0.885, and sensitivity is 0.602. CONCLUSION: Our study reveals that there were 8 variables that can be considered as independent risk factors for HUA among T2DM patients. In light of our findings, a predictive model was developed and clinical advice was given on its use. BioMed Central 2023-09-07 /pmc/articles/PMC10483783/ /pubmed/37679683 http://dx.doi.org/10.1186/s12889-023-16669-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Abudureyimu, Palizhati
Pang, Yuesheng
Huang, Lirun
Luo, Qianqian
Zhang, Xiaozheng
Xu, Yifan
Jiang, Liang
Mohemaiti, Patamu
A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title_full A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title_fullStr A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title_full_unstemmed A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title_short A predictive model for hyperuricemia among type 2 diabetes mellitus patients in Urumqi, China
title_sort predictive model for hyperuricemia among type 2 diabetes mellitus patients in urumqi, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483783/
https://www.ncbi.nlm.nih.gov/pubmed/37679683
http://dx.doi.org/10.1186/s12889-023-16669-6
work_keys_str_mv AT abudureyimupalizhati apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT pangyuesheng apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT huanglirun apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT luoqianqian apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT zhangxiaozheng apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT xuyifan apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT jiangliang apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT mohemaitipatamu apredictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT abudureyimupalizhati predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT pangyuesheng predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT huanglirun predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT luoqianqian predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT zhangxiaozheng predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT xuyifan predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT jiangliang predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina
AT mohemaitipatamu predictivemodelforhyperuricemiaamongtype2diabetesmellituspatientsinurumqichina